Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: A randomized trial may not be necessary in high-risk patients

Europace

Volumn 11, Issue 4, 2009, Pages 537-

  Bestetti, Reinaldo ^a   Cardinalli Neto, Augusto ^a  

^a Faculdade de Medicina   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CHAGAS DISEASE; CHRONIC DISEASE; DEFIBRILLATION; DEFIBRILLATOR; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMPLANTATION; LETTER; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; SUDDEN DEATH;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CHRONIC DISEASE; DEFIBRILLATORS, IMPLANTABLE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOTALOL; TACHYCARDIA, VENTRICULAR; TRYPANOSOMA CRUZI;

EID: 65249086193     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup060     Document Type: Letter

References (6)

1. Muratore CA, Sá LAB, Chiale PA, Eloy R, Tentori MC, Escudero J et al. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Europace 2009;11: 164-8.
2. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VA. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 2007;18:1236-40.
3. Leite LR, Fenelon G, Simões A Jr, Silva GG, Friedman PA, de Paola AAV. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol 2003;14:567-73.
4. Cardinalli-Neto A, Greco OT, Bestetti RB. Automatic implantable cardioverter defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias. Pacing Clin Electrophysiol 2006;29: 467-70.
5. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS et al. ACC/AHA/HRS guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 2008;117: e350-408.
6. Exner DV, Klein GJ. Do we need a randomized trial of defibrillator therapy in every subset of patients with increased risk of sudden death? J Cardiovasc Electrophysiol 2003;14:574-7.